BUFFALO, N.Y. (AP) _ Athenex Inc. (ATNX) on Tuesday reported a loss of $36.9 million in its second quarter.
On a per-share basis, the Buffalo, New York-based company said it had a loss of 58 cents.
The biopharmaceutical company posted revenue of $11.6 million in the period.
Athenex expects full-year revenue in the range of $100 million to $125 million.
Athenex shares have risen 14 percent since the beginning of the year. The stock has climbed 24 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNX at https://www.zacks.com/ap/ATNX